Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387712 · ClinicalTrials.gov registry record · NA
Inflammatory Abnormalities in Muscle After Stroke: Effects of Exercise
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT00387712: Completed NA study, sponsored by VA Office of Research and Development.
NCT00387712 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00387712, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to first define whether abnormalities of skeletal muscle are related to the presence of inflammation and to poor motor performance and whether this can be modified by exercise interventions.
Primary Outcome
Cardiovascular fitness is measured by collecting the expired gases during a progressive graded treadmill test.
Interventions
- OTHER Velocity based treadmill training
- OTHER Duration based treadmill training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2006-10 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT00387712 record still lists
NCT00387712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Velocity based treadmill training is the first listed.
NCT00387712 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00387712 about?
NCT00387712 is a clinical study titled "Inflammatory Abnormalities in Muscle After Stroke: Effects of Exercise". The purpose of this study is to first define whether abnormalities of skeletal muscle are related to the presence of inflammation and to poor motor performance and whether this can be modified by exercise interventions.
What is the current status of trial NCT00387712?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2006-10. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00387712?
The interventions under investigation include: Velocity based treadmill training (OTHER), Duration based treadmill training (OTHER).
Who is sponsoring clinical trial NCT00387712?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00387712's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia